Communiqués JMDC Inc.

Actions

4483

JP3386690006

Services d'assistance aux entreprises

Marché Fermé - Japan Exchange 08:30:00 14/08/2026			Varia. 5j.	Varia. 1 janv.
3 470,00 ^JPY	+1,61%		+2,81%	-12,92%

05/08	JMDC Inc. publie ses prévisions de résultats consolidés pour le semestre clos au 30 septembre 2026 et l'exercice clos au 31 mars 2027	CI
05/08	JMDC Inc. publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Communiqués

08/05	JMDC : Summary of Financial Statements for the Fiscal Year Ended March 31, 2026 (Consolidated)	PU
08/05	JMDC : FY2025 Financial Briefing Material	PU
06/11	JMDC : Summary of Financial Statements for the Six Months Ended September 30, 2025 (Consolidated)	PU
06/11	JMDC : FY2025 Q2 Financial Briefing Material	PU
06/08/25	JMDC : Summary of Financial Statements for the Three Months Ended June 30, 2026 (Consolidated)	PU
06/08/25	JMDC : FY2025 Q1 Financial Briefing Material	PU
07/05/24	JMDC : FY2023 Financial Briefing Material	PU
02/11/23	JMDC : Summary of Financial Statements for the Six Months Ended September 30, 2023 (Consolidated)	PU
02/11/23	JMDC : FY2023 Q2 Financial Briefing Material	PU
09/08/23	JMDC : Summary of Financial Statements for the Three Months Ended June 30, 2023 (Consolidated)	PU
09/08/23	JMDC : FY2023 Q1 Financial Briefing Material	PU
27/07/22	JMDC : Notice Concerning Borrowing of Funds	PU
20/07/22	JMDC : (Progress of disclosure matters)Notice of Additional Acquisition of Shares in Real World Data	PU
12/07/22	JMDC : Supplementary materials concerning acquisition of shares in Real World Data (to make it JMDC’s subsidiary)	PU
12/07/22	JMDC : Notice of Acquisition of Shares in Real World Data (to Make It JMDC’s Subsidiary)	PU
01/07/22	JMDC : Notice of Our New Initiative in the Field of Clinical Trials	PU
23/05/22	JMDC : Notice of Partial Amendment of Articles of Incorporation	PU
24/02/22	JMDC : Explanation Material on the Capital and Business Partnership with OMRON Corporation	PU
22/02/22	JMDC : Notice of Partnership with OMRON Corporation, Secondary Offering of Shares, and Changes in Parent Company, etc., and the Major and Largest Shareholder	PU
07/02/22	JMDC : FY2021 Q3 Financial Briefing Material	PU
07/02/22	JMDC : Summary of Financial Statements for the Nine Months Ended December 31, 2021 (Consolidated)	PU
20/12/21	JMDC : Notice Concerning Application for Selecting Prime Market in the New Market Segments	PU
16/12/21	JMDC : First Pharmaceutical Approval in Japan for Chest X-ray AI Algorithm that Supports Diagnosis of Patients with Infectious Pneumonia, Including COVID-19	PU
29/11/21	JMDC : Notice of Listing Market Change to the First Section of the Tokyo Stock Exchange	PU
22/11/21	JMDC : Notice of Approval for Change of Listing Market to the First Section ofthe Tokyo Stock Exchange	PU